ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 1228

Spine Immobilization and Neurological Complications in Vertebral Osteomyelitis: Results from a Multicenter Prospective Observational Study

Géraldine Bart1, Guillaume Coiffier2, Oriane Merot3, Emmanuel Hoppe4, Marion Couderc5, Denis Mulleman6, Gregoire Cormier7, Jean Marc Ziza8 and Benoit Le Goff1, 1Rheumatology, Nantes University Hospital, Nantes, France, 2Rheumatology, Rennes University Hospital, Rennes, France, 3rheumatology unit, Saint Nazaire Hospital, Saint Nazaire, France, 4Angers University Hospital, Angers, France, 5Rheumatology, CHU Gabriel Montpied, Clermont-Ferrand, France, 6Université François-Rabelais de Tours, CNRS 7292, Tours, France, 7Service de Rhumatologie, CHD de la Roche-Sur-Yon, La Roche-Sur-Yon, France, 8Medecine Interne-Rhumatologie, Groupe hospitalier Diaconesses-Croix-Saint-Simon, Paris, France

Meeting: ACR/ARHP Annual Meeting 2018

Keywords: Infection, Neurologic involvement, osteomyelitis and spine involvement

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Infection-related Rheumatic Disease Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: In a previous work, we showed that neurological complication can occur in up to 40% of patients with vertebral osteomyelitis (VO). Bed rest and spine immobilization are usually prescribed to prevent those complications. There is currently no consensus about the best immobilization protocol to follow in VO. Objectives of our work were to assess the prescription of spine immobilization for VO and its effect of neurological complications.

Methods: A prospective study was performed in 10 centers. All patients with native VO were included and followed prospectively: neurological complications, imaging findings, type and duration of immobilization were reported and patients were divided in two groups: “Immobilization” or “No Immobilization”, regarding if they had a prescription of spine bracing or not. We present here the data of our study after 6 months of follow-up.

Results:

To date, 102 patients were included: 72 in the “Immobilization” group, and 30 in the “No Immobilization” group. Median duration of symptoms before diagnosis was 27 days, IQR (11-40).

Thirty-six percent of the patients (n=37) had an abnormal neurological exam at baseline: 23.5% (n=24) had minor neurological signs (sensory loss or radiculopathy), and 12.7% (n=13) had major neurological signs (motor deficit or cauda equine syndrome). During hospital stay, 4 patients developed major neurological signs (median 5 days after diagnosis) and 5 patients developed minor neurological signs (median 6 days after diagnosis). Half of the patients with abnormal neurological exam at baseline had a normal neurological examination at 6 months.

Median duration of bed rest was 9 days (IQR 7-18). In the “Immobilization” group (n=72), median duration of spine bracing was 8 weeks, IQR (6-12) and it was rigid bracing in 90% of cases. Main characteristics of the 2 groups are described in Table 1. They were no significant differences in age, associated diseases, or pathogen. Only one patient in the “No Immobilization” Group developed a paraplegia during follow-up, and the reason of the absence of immobilization was unclear. All patients with cervical involvement had a prescription of spine immobilization, whereas only half of the patients with lumbar involvement were immobilized. There were significantly less thoracic spine involvement in the “Immobilization” group. There were no differences in terms of neurological complications during follow-up between the two groups.

Immobilization

n= 72 (%)

No immobilization

n=30 (%)

p

Demographical characteristics

Age, years (standard deviation)

65 (+/- 15)

72 (+/- 14)

NS

Male

51 (70.8)

17 (56.6)

0,18

Diabetes

14 (19.4)

8 (26.6)

0,4

Obesity (BMI>30kg/M2)

17 (23.6)

8 (26.6)

0,7

Level of vertebraes involved

Multifocal

11 (15.3)

9 (30)

0,09

Lumbar

37 (51.4)

16 (53.3)

0,8

Thoracic

18 (25)

14 (46.6)

0,03

Cervical

13 (18.1)

0

NS

Pathogen

Staphylococcus aureus

22 (30.5)

12 (40)

0,3

Neurological state

Major neurological sign at baseline

7 (9.7)

5 (16.6)

0,3

Minor neurological sign at baseline

20 (27.7)

4 (13.3)

0,11

Major neurological sign occurring during follow up

3 (4.2)

1 (3.3)

0,8

Minor neurological sign occurring during follow up

5 (6.9)

0

NS

Conclusion:

Neurological complications occurred in 36% of our patients. Interestingly, 30% of our patients were not immobilized. None of them had cervical involvement and neurological outcome was favorable for 95% of “Not Immobilized” patients.


Disclosure: G. Bart, None; G. Coiffier, None; O. Merot, None; E. Hoppe, None; M. Couderc, None; D. Mulleman, None; G. Cormier, None; J. M. Ziza, None; B. Le Goff, None.

To cite this abstract in AMA style:

Bart G, Coiffier G, Merot O, Hoppe E, Couderc M, Mulleman D, Cormier G, Ziza JM, Le Goff B. Spine Immobilization and Neurological Complications in Vertebral Osteomyelitis: Results from a Multicenter Prospective Observational Study [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/spine-immobilization-and-neurological-complications-in-vertebral-osteomyelitis-results-from-a-multicenter-prospective-observational-study/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR/ARHP Annual Meeting 2018

ACR Meeting Abstracts - https://acrabstracts.org/abstract/spine-immobilization-and-neurological-complications-in-vertebral-osteomyelitis-results-from-a-multicenter-prospective-observational-study/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology